ERGIC3 Antikörper (N-Term)
-
- Target Alle ERGIC3 Antikörper anzeigen
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Bindungsspezifität
- AA 1-30, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ERGIC3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human ERGIC3 (N-term).
- Aufreinigung
- Affinity Chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 1~30 amino acids from the N-terminal region of Human ERGIC3
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product ERGIC3 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
- Andere Bezeichnung
- ERGIC3 (ERGIC3 Produkte)
- Hintergrund
- ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.Synonyms: C20orf47, CGI-54, ERV46, Endoplasmic reticulum-Golgi intermediate compartment protein 3, NY-BR-84, PRO0989, SDBCAG84, Serologically defined breast cancer antigen NY-BR-84
- Molekulargewicht
- 43222 Da
- Gen-ID
- 51614
- NCBI Accession
- NP_057050
-